APLS vs ORLY · rev $1.00B vs P/E 34, rev $9.45B
Apellis Pharmaceuticals Inc (APLS) versus O’Reilly Automotive Inc (ORLY) — a side-by-side from cached financials, not a winner call.
Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
O’Reilly Automotive Inc (ORLY) is a auto parts company listed on US.
Latest reported APLS revenue for 2025-12-31 was $1.00B. Net income was $22.4M. Revenue was up 28.5% from 2024-12-31 to 2025-12-31. APLS currently screens at market cap $2.29B.
Latest reported ORLY revenue for 2026-06-30 was $9.45B. Net income was $1.32B. ORLY currently screens at market cap $78.32B and trailing P/E 33.7.
APLS currently screens at market cap $2.29B. ORLY currently screens at market cap $78.32B and trailing P/E 33.7.
Not investment advice. Open the APLS and ORLY stock pages for the full models.
Not investment advice.